First transcatheter aortic valve implantation for severe pure aortic regurgitation in Asia.

Chiam Paul, Ewe SH, Chua YL, Lim YT.

Singapore Medical Journal 2014; 56: e1-e3.


Transcatheter aortic valve implantation (TAVI) has become the standard of care for inoperable patients with symptomatic severe aortic stenosis (AS), and an alternative to open aortic valve replacement for patients at high surgical risk. TAVI has also been performed in several groups of patients with off-label indications such as severe bicuspid AS, and as a valve-in-valvetherapy for a degenerated surgical bioprosthesis. Although TAVI with CoreValve® prosthesis is technically challenging, and global experience in the procedure is limited, the procedure could be a treatment option for well-selected patients with severe pure aortic regurgitation (AR). Herein, we report Asia‘s first case of TAVI for severe pure AR in a patient who was at extreme surgical risk, with good clinical outcome at six months.

Contact Us

    Input this code: captcha

    +65 6735 3022

    Call Us Now!

    For an appointment.

    Privacy Settings
    We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
    Consent to display content from Youtube
    Consent to display content from Vimeo
    Google Maps
    Consent to display content from Google